vs

Side-by-side financial comparison of Anterix Inc. (ATEX) and CuriosityStream Inc. (CURI). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $1.6M, roughly 12.2× Anterix Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -419.6%, a 399.9% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs 0.4%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-8.3M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 11.7%).

Anterix Inc. is a U.S.-headquartered wireless communications company that owns licensed 900 MHz spectrum assets, providing secure, dedicated private broadband network solutions for critical infrastructure operators including electric utilities, public safety agencies, and transportation providers. Its primary market is North America, supporting clients requiring highly reliable connectivity for mission-critical operations.

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

ATEX vs CURI — Head-to-Head

Bigger by revenue
CURI
CURI
12.2× larger
CURI
$19.2M
$1.6M
ATEX
Growing faster (revenue YoY)
CURI
CURI
+35.4% gap
CURI
35.8%
0.4%
ATEX
Higher net margin
CURI
CURI
399.9% more per $
CURI
-19.7%
-419.6%
ATEX
More free cash flow
CURI
CURI
$12.2M more FCF
CURI
$3.9M
$-8.3M
ATEX
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
11.7%
ATEX

Income Statement — Q3 2026 vs Q4 2025

Metric
ATEX
ATEX
CURI
CURI
Revenue
$1.6M
$19.2M
Net Profit
$-6.6M
$-3.8M
Gross Margin
Operating Margin
-576.0%
-17.6%
Net Margin
-419.6%
-19.7%
Revenue YoY
0.4%
35.8%
Net Profit YoY
-185.6%
-34.6%
EPS (diluted)
$-0.35
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATEX
ATEX
CURI
CURI
Q4 25
$1.6M
$19.2M
Q3 25
$1.6M
$18.4M
Q2 25
$1.4M
$19.0M
Q1 25
$1.4M
$15.1M
Q4 24
$1.6M
$14.1M
Q3 24
$1.6M
$12.6M
Q2 24
$1.5M
$12.4M
Q1 24
$1.3M
$12.0M
Net Profit
ATEX
ATEX
CURI
CURI
Q4 25
$-6.6M
$-3.8M
Q3 25
$53.5M
$-3.7M
Q2 25
$25.2M
$784.0K
Q1 25
$9.2M
$319.0K
Q4 24
$7.7M
$-2.8M
Q3 24
$-12.8M
$-3.1M
Q2 24
$-15.5M
$-2.0M
Q1 24
$-9.4M
$-5.0M
Operating Margin
ATEX
ATEX
CURI
CURI
Q4 25
-576.0%
-17.6%
Q3 25
-24.5%
Q2 25
2.5%
Q1 25
0.5%
Q4 24
-27.4%
Q3 24
-846.6%
-25.8%
Q2 24
-984.4%
-20.6%
Q1 24
-834.2%
-30.4%
Net Margin
ATEX
ATEX
CURI
CURI
Q4 25
-419.6%
-19.7%
Q3 25
3449.5%
-20.4%
Q2 25
1775.7%
4.1%
Q1 25
662.9%
2.1%
Q4 24
492.3%
-19.9%
Q3 24
-823.1%
-24.3%
Q2 24
-1018.0%
-16.4%
Q1 24
-746.9%
-42.0%
EPS (diluted)
ATEX
ATEX
CURI
CURI
Q4 25
$-0.35
$-0.07
Q3 25
$2.86
$-0.06
Q2 25
$1.35
$0.01
Q1 25
$0.51
$0.01
Q4 24
$0.41
$-0.05
Q3 24
$-0.69
$-0.06
Q2 24
$-0.84
$-0.04
Q1 24
$-0.51
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATEX
ATEX
CURI
CURI
Cash + ST InvestmentsLiquidity on hand
$29.5M
$27.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$236.0M
$41.5M
Total Assets
$417.0M
$75.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATEX
ATEX
CURI
CURI
Q4 25
$29.5M
$27.3M
Q3 25
$39.1M
$27.8M
Q2 25
$41.4M
$28.1M
Q1 25
$47.4M
$33.4M
Q4 24
$28.8M
$32.1M
Q3 24
$43.1M
$33.2M
Q2 24
$51.7M
$39.5M
Q1 24
$60.6M
$38.8M
Stockholders' Equity
ATEX
ATEX
CURI
CURI
Q4 25
$236.0M
$41.5M
Q3 25
$240.3M
$47.2M
Q2 25
$184.8M
$49.8M
Q1 25
$156.6M
$58.1M
Q4 24
$144.7M
$57.8M
Q3 24
$139.1M
$62.2M
Q2 24
$148.8M
$64.8M
Q1 24
$161.0M
$67.0M
Total Assets
ATEX
ATEX
CURI
CURI
Q4 25
$417.0M
$75.7M
Q3 25
$420.4M
$74.7M
Q2 25
$359.6M
$78.7M
Q1 25
$333.1M
$85.3M
Q4 24
$326.7M
$86.2M
Q3 24
$317.2M
$87.6M
Q2 24
$321.1M
$90.9M
Q1 24
$324.9M
$94.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATEX
ATEX
CURI
CURI
Operating Cash FlowLast quarter
$-8.3M
$4.0M
Free Cash FlowOCF − Capex
$-8.3M
$3.9M
FCF MarginFCF / Revenue
-526.4%
20.5%
Capex IntensityCapex / Revenue
0.6%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATEX
ATEX
CURI
CURI
Q4 25
$-8.3M
$4.0M
Q3 25
$1.4M
$4.4M
Q2 25
$-3.1M
$2.8M
Q1 25
$-16.6M
$1.9M
Q4 24
$-7.7M
$3.0M
Q3 24
$-2.6M
$2.3M
Q2 24
$-2.4M
$2.2M
Q1 24
$6.1M
$666.0K
Free Cash Flow
ATEX
ATEX
CURI
CURI
Q4 25
$-8.3M
$3.9M
Q3 25
Q2 25
Q1 25
$-16.6M
$1.8M
Q4 24
Q3 24
$-2.7M
Q2 24
Q1 24
$6.1M
FCF Margin
ATEX
ATEX
CURI
CURI
Q4 25
-526.4%
20.5%
Q3 25
Q2 25
Q1 25
-1195.2%
12.2%
Q4 24
Q3 24
-173.4%
Q2 24
Q1 24
484.1%
Capex Intensity
ATEX
ATEX
CURI
CURI
Q4 25
0.6%
0.1%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
3.3%
0.5%
Q4 24
0.0%
0.0%
Q3 24
2.6%
0.0%
Q2 24
0.0%
0.0%
Q1 24
3.2%
0.0%
Cash Conversion
ATEX
ATEX
CURI
CURI
Q4 25
Q3 25
0.03×
Q2 25
-0.12×
3.56×
Q1 25
-1.80×
6.03×
Q4 24
-1.00×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons